Prevalence of Past and Reactivated Viral Infections and Efficacy of Cyclosporine A as Monotherapy or in Combination in Patients with Psoriatic Arthritis—Synergy Study: A Longitudinal Observational Study
Table 1
Demographic and clinical characteristics at baseline.
Sex, number (%)
Male
121 (54)
Female
104 (46)
Age (years, mean ± SD)
Male
48.9 ± 12.8
Female
50.8 ± 12.5
Treating physician, number (%)
Dermatologist
166 (73.8)
Rheumatologist
52 (23.1)
Both
4 (1.8)
Age at diagnosis of psoriasis (years, mean ± SD)
38.3 ± 15.6
Age at diagnosis of psoriatic arthritis (years, mean ± SD)
47.6 ± 12.4
PASI, median (IQ25–75)
4.7 (0.8–11.8)
BASDAI, median (IQ25–75)
40.8 (23.5–56.8)
Classification according to joint involvement, %1
Monoarticular
19 (8.4)
Oligoarticular
81 (36.0)
Polyarticular
92 (41.0)
Spondylotic
36 (16.0)
Enthesic
40 (18)
Comorbidities, no. (%)
Cardiovascular
62 (27.6)
Diabetes mellitus type 2
13 (5.8)
Diabetes mellitus type 1
4 (1.8)
Renal disease
5 (2.2)
Cancer
1 (0.4)
Hepatitis B
1 (0.4)
Other
49 (21.8)
Data refer to 225 patients except for BASDAI (61 evaluable patients). PASI: Psoriasis Area Severity Index; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index. 1Patients can be classified in more than one group.
